{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:08:47Z","timestamp":1788966527220,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10787-026-02353-9","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:55:25Z","timestamp":1787219725000},"page":"5891-5900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-dose aspirin in pregnancy: indications, efficacy, safety, and remaining controversies"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8399-1230","authenticated-orcid":false,"given":"Sabina","family":"Yasmin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"3","key":"2353_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0020-7292(90)91068-2","volume":"31","author":"GB Al Gregorini","year":"1990","unstructured":"Al Gregorini GB, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R, Gastaldi A, Remuzzi G (1990) Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. Int J Gynecol Obstet 31(3):306\u2013307","journal-title":"Int J Gynecol Obstet"},{"issue":"2 Part 1","key":"2353_CR2","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116(2 Part 1):402\u2013414","journal-title":"Obstet Gynecol"},{"key":"2353_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40256-020-00409-x","volume":"21","author":"B Mainoli","year":"2021","unstructured":"Mainoli B, Duarte GS, Costa J, Ferreira J, Caldeira D (2021) Once-versus twice-daily aspirin in patients at high risk of thrombotic events: systematic review and meta-analysis. Am J Cardiovasc Drug 21:63\u201371","journal-title":"Am J Cardiovasc Drug"},{"issue":"8","key":"2353_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/L14-5020-4","volume":"161","author":"S Roberge","year":"2014","unstructured":"Roberge S, Demers S, Bujold E (2014) Low-dose aspirin for prevention of morbidity and mortality from preeclampsia. Ann Intern Med 161(8):613","journal-title":"Ann Intern Med"},{"key":"2353_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","volume":"4","author":"S Awate","year":"2013","unstructured":"Awate S, Babiuk LA, Mutwiri G (2013) Mechanisms of action of adjuvants. Front Immunol 4:114","journal-title":"Front Immunol"},{"issue":"10","key":"2353_CR6","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/01.STR.23.10.1400","volume":"23","author":"H Tohgi","year":"1992","unstructured":"Tohgi H, Konno S, Tamura K, Kimura B, Kawano K (1992) Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke 23(10):1400\u20131403","journal-title":"Stroke"},{"issue":"2","key":"2353_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1530\/REP-11-0021","volume":"142","author":"LJ Macdonald","year":"2011","unstructured":"Macdonald LJ, Boddy SC, Denison FC, Sales KJ, Jabbour HN (2011) A role for lipoxin A4 as an anti-inflammatory mediator in the human endometrium. Reprod (Cambridge England) 142(2):345","journal-title":"Reprod (Cambridge England)"},{"issue":"21","key":"2353_CR8","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1001\/jama.2012.5034","volume":"307","author":"G De Berardis","year":"2012","unstructured":"De Berardis G, Lucisano G, D\u2019Ettorre A, Pellegrini F, Lepore V, Tognoni G, Nicolucci A (2012) Association of aspirin use with major bleeding in patients with and without diabetes. JAMA 307(21):2286\u20132294","journal-title":"JAMA"},{"issue":"2","key":"2353_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ajog.2021.08.004","volume":"226","author":"L Lin","year":"2022","unstructured":"Lin L, Huai J, Li B, Zhu Y, Juan J, Zhang M, Cui S, Zhao X, Ma Y, Zhao Y, Mi Y (2022) A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol 226(2):251\u2013e1","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"2353_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0022-3476(79)80043-8","volume":"94","author":"DL Levin","year":"1979","unstructured":"Levin DL, Mills LJ, Parkey M, Garriott J, Campbell W (1979) Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe. J Pediatr-Us 94(4):647\u2013650","journal-title":"J Pediatr-Us"},{"issue":"11","key":"2353_CR11","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/aogs.13420","volume":"97","author":"L Blomqvist","year":"2018","unstructured":"Blomqvist L, Hellgren M, Strandell A (2018) Acetylsalicylic acid does not prevent first-trimester unexplained recurrent pregnancy loss: A randomized controlled trial. Acta Obstet Gyn Scan 97(11):1365\u20131372","journal-title":"Acta Obstet Gyn Scan"},{"issue":"7839","key":"2353_CR12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(73)92934-6","volume":"302","author":"R Lewis","year":"1973","unstructured":"Lewis R, Schulman J (1973) Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 302(7839):1159\u20131161","journal-title":"Lancet"},{"issue":"15","key":"2353_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1056\/NEJM198210073071502","volume":"307","author":"MJ Stuart","year":"1982","unstructured":"Stuart MJ, Gross SJ, Elrad H, Graeber JE (1982) Effects of acetylsalicylic acid ingestion on maternal and neonatal hemostasis. New Engl J Med 307(15):909\u2013912","journal-title":"New Engl J Med"},{"issue":"7930","key":"2353_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0140-6736(75)92777-4","volume":"306","author":"E Collins","year":"1975","unstructured":"Collins E, Turner G (1975) Maternal effects of regular salicylate ingestion in pregnancy. Lancet 306(7930):335\u2013338","journal-title":"Lancet"},{"issue":"2","key":"2353_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0022-3476(71)80122-1","volume":"79","author":"DG Corby","year":"1971","unstructured":"Corby DG, Schulman I (1971) The effects of antenatal drug administration on aggregation of platelets of newborn infants. J Pediatr-Us 79(2):307\u2013313","journal-title":"J Pediatr-Us"},{"issue":"4","key":"2353_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S0022-3476(74)80678-5","volume":"84","author":"RR Haslam","year":"1974","unstructured":"Haslam RR, Ekert H, Gillam GL (1974) Hemorrhage in a neonate possibly due to maternal ingestion of salicylate. J Pediatr-Us 84(4):556\u2013557","journal-title":"J Pediatr-Us"},{"issue":"6","key":"2353_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/000992287301200609","volume":"12","author":"JR Mcniel","year":"1973","unstructured":"Mcniel JR (1973) The possible teratogenic effect of salicylates on the developing fetus: Brief summaries of eight suggestive cases. Clin Pediatr 12(6):347\u2013350","journal-title":"Clin Pediatr"},{"issue":"4","key":"2353_CR18","first-page":"218","volume":"23","author":"ID Richards","year":"1969","unstructured":"Richards ID (1969) Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med 23(4):218","journal-title":"Br J Prev Soc Med"},{"key":"2353_CR19","doi-asserted-by":"publisher","first-page":"101244","DOI":"10.1016\/j.preghy.2025.101244","volume":"41","author":"JM bij de Weg","year":"2025","unstructured":"bij de Weg JM, de Groot CJ, de Vries JI, de Boer MA (2025) Adherence to aspirin in the prevention of pregnancy complications: a systematic review. Pregnancy Hypertens 41:101244","journal-title":"Pregnancy Hypertens"},{"issue":"4","key":"2353_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ajog.2023.04.031","volume":"229","author":"R Horgan","year":"2023","unstructured":"Horgan R, Diab YH, Waller J, Abuhamad A, Saade G (2023) Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations? Am J Obstet Gynecol 229(4):410\u2013418","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2353_CR21","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.ajogmf.2025.101620","volume":"7","author":"ME Pullins","year":"2025","unstructured":"Pullins ME, Boggess KA (2025) Aspirin dosage for preeclampsia prophylaxis: an argument for 162-mg dosing. Am J Obstet Gynecol MFM 7(1):101620","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2353_CR22","doi-asserted-by":"publisher","first-page":"101247","DOI":"10.1016\/j.preghy.2025.101247","volume":"41","author":"M Badarna","year":"2025","unstructured":"Badarna M, Hoffman N, Stern S, Kayal RS, Aiob A, Lowenstein L, Sgayer I (2025) The timing of discontinuation of low-dose aspirin and postpartum hemorrhage risk. Pregnancy Hypertens 41:101247.https:\/\/doi.org\/10.1016\/j.preghy.2025.101247. Epub 2025 Aug 12. PMID: 40803056","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"2353_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/a-2681-6377","volume":"43","author":"D Maldonado","year":"2026","unstructured":"Maldonado D, Cao M, Geraci S, Drohan L, Walker E, Yang X, Divers J, Suhag A (2026) A Quality Improvement Initiative to Optimize Low-Dose Aspirin Use in Patients with Moderate Risk Factors for Preeclampsia. Am J Perinatol 43(6):729\u2013735.https:\/\/doi.org\/10.1055\/a-2681-6377. Epub 2025 Aug 12. PMID: 40795925","journal-title":"Am J Perinatol"},{"issue":"4","key":"2353_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.34172\/aim.33275","volume":"28","author":"W Wang","year":"2025","unstructured":"Wang W, Chang G (2025) Evaluation of Low-Dose Aspirin on Pregnancy Outcomes: A Systematic Review and Meta-analysis. Arch Iran Med 28(4):225","journal-title":"Arch Iran Med"},{"issue":"9","key":"2353_CR25","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/HYPERTENSIONAHA.125.25342","volume":"82","author":"S Huang","year":"2025","unstructured":"Huang S, Zhang Y, Guo Y, Zhang Y, Huang J, Yang Y, Qi Q, Zhao L, Xu X, Shen Y, Liang C (2025) Constructing a Preeclampsia Organoid Model to Elucidate the Mechanism of Aspirin. Hypertension 82(9):e171\u2013e185","journal-title":"Hypertension"},{"issue":"8","key":"2353_CR26","first-page":"1316","volume":"82","author":"MM Ngwira","year":"2025","unstructured":"Ngwira MM, Makris A, Shanmugalingam R, Mbotwa JL, Mayani J, Gadama LA, Hennessy A (2025) Calcium Aspirin Preeclampsia Early Prevention and Response (CASPER) Trial in Blantyre, Malawi: A Double-Blinded. Cluster Randomized Trial Hypertens 82(8):1316\u20131325 Epub 2025 Jun 9. PMID: 40485444","journal-title":"Cluster Randomized Trial Hypertens"},{"issue":"5","key":"2353_CR27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"G Obstetricians ACo","year":"2013","unstructured":"Obstetricians ACo G (2013) Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 task force on hypertension in pregnancy. Obstet gynecol 122(5):1122","journal-title":"Obstet gynecol"},{"issue":"2","key":"2353_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/jhh.2009.45","volume":"24","author":"LC Poon","year":"2010","unstructured":"Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH (2010) Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 24(2):104\u2013110","journal-title":"J Hum Hypertens"},{"key":"2353_CR29","doi-asserted-by":"crossref","unstructured":"Beroyz G, Casale R, Farreiros A, Palermo M, Margulies M, Voto L, Fabregues G, Ramalingam R, Davies T, Bryce R, Boyd W (1994) CLASP-A randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant-women. Lancet. ;343(8898)","DOI":"10.1016\/S0140-6736(94)92633-6"},{"issue":"10","key":"2353_CR30","doi-asserted-by":"publisher","first-page":"CD004659","DOI":"10.1002\/14651858.CD004659.pub3","volume":"2019","author":"L Duley","year":"2019","unstructured":"Duley L, Meher S, Hunter KE, Seidler AL, Askie LM (2019) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2019(10):CD004659.https:\/\/doi.org\/10.1002\/14651858.CD004659.pub3. PMID: 31684684; PMCID: PMC6820858","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2353_CR31","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1093\/cvr\/cvy107","volume":"114","author":"B Thilaganathan","year":"2018","unstructured":"Thilaganathan B (2018) The ASPRE pre-eclampsia trial: implications for basic research and clinical practice. Cardiovasc Res 114(8):e60\u2013e61","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2353_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0002-9378(94)70056-7","volume":"171","author":"TG Di Sessa","year":"1994","unstructured":"Di Sessa TG, Moretti ML, Khoury A, Pulliam DA, Arheart KL, Sibai BM (1994) Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. Am J Obstet Gynecol 171(4):892\u2013900","journal-title":"Am J Obstet Gynecol"},{"issue":"02","key":"2353_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/s-2005-864116","volume":"209","author":"B Schiessl","year":"2005","unstructured":"Schiessl B, Schneider KT, Zimmermann A, Kainer F, Friese K, Oberhoffer R (2005) Prenatal constriction of the fetal ductus arteriosus-related to maternal pain medication? Z f\u00fcr Geburtshilfe und Neonatologie 209(02):65\u201368","journal-title":"Z f\u00fcr Geburtshilfe und Neonatologie"},{"issue":"6","key":"2353_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2350\/07-11-0368.1","volume":"14","author":"J Wyatt-Ashmead","year":"2011","unstructured":"Wyatt-Ashmead J (2011) Antenatal closure of the ductus arteriosus and hydrops fetalis. Pediatr Devel Pathol 14(6):469\u2013474","journal-title":"Pediatr Devel Pathol"},{"issue":"24","key":"2353_CR35","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM198912143212404","volume":"321","author":"MM Werler","year":"1989","unstructured":"Werler MM, Mitchell AA, Shapiro S (1989) The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. New Engl J Med 321(24):1639\u20131642","journal-title":"New Engl J Med"},{"issue":"3","key":"2353_CR36","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","volume":"192","author":"B N\u00f8rg\u00e5rd","year":"2005","unstructured":"N\u00f8rg\u00e5rd B, Puh\u00f3 E, Czeizel AE, Skriver MV, S\u00f8rensen HT (2005) Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol 192(3):922\u2013923","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2353_CR37","first-page":"1165","volume":"79","author":"EP Vandermeulen","year":"1994","unstructured":"Vandermeulen EP, Van Aken H, Vermylen J (1994) Anticoagulants and spinal-epidural anesthesia. AnesthAnalg 79(6):1165\u20131177","journal-title":"AnesthAnalg"},{"issue":"2 Part 1","key":"2353_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","volume":"116","author":"E Bujold","year":"2010","unstructured":"Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y (2010) Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116(2 Part 1):402\u2013414","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2353_CR39","doi-asserted-by":"publisher","first-page":"e0275129","DOI":"10.1371\/journal.pone.0275129","volume":"17","author":"C Diguisto","year":"2022","unstructured":"Diguisto C, Le Gouge A, Marchand MS, Megier P, Ville Y, Haddad G, Winer N, Arthuis C, Doret M, Debarge VH, Flandrin A (2022) Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial. PLoS ONE 17(10):e0275129","journal-title":"PLoS ONE"},{"issue":"2","key":"2353_CR40","first-page":"65","volume":"33","author":"AR Mather","year":"2021","unstructured":"Mather AR, Dom AM, Thorburg LL (2021) Low-dose aspirin in pregnancy: who? when? how much? and why?CurrOpinObstet. Gyn 33(2):65\u201371","journal-title":"Gyn"},{"issue":"2","key":"2353_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajog.2016.09.086","volume":"216","author":"F Mone","year":"2017","unstructured":"Mone F, Mulcahy C, McParland P, McAuliffe FM (2017) Should we recommend universal aspirin for all pregnant women? Am J Obstet Gynecol 216(2):141\u2013e1","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2353_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0002-9378(99)70163-8","volume":"180","author":"A Dumont","year":"1999","unstructured":"Dumont A, Flahault A, Beaufils M, Verdy E, Uzan S (1999) Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol 180(1):135\u2013140","journal-title":"Am J Obstet Gynecol"},{"issue":"1\u20132","key":"2353_CR43","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/07420528.2012.717455","volume":"30","author":"DE Ayala","year":"2013","unstructured":"Ayala DE, Ucieda R, Hermida RC (2013) Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int 30(1\u20132):260\u2013279","journal-title":"Chronobiol Int"},{"key":"2353_CR44","doi-asserted-by":"crossref","unstructured":"Rodriguez-Sibaja MJ, Galvez-Rubalcava N, Hagerman-Sucar G, Camarena PA, Gomez-Woodworth JR, Villalpando-Juarez MI, Acevedo-Gallegos S, Velazquez-Torres B, Ramirez-Calvo JA, Copado-Mendoza DY, Lumbreras-Marquez MI (2025) Maternal, fetal, and neonatal serious adverse events associated with low-dose aspirin during the first trimester of pregnancy: A secondary analysis of the ASPIRIN trial. Am J Obstet Gynecol MFM 18:101768","DOI":"10.1016\/j.ajogmf.2025.101768"},{"issue":"2","key":"2353_CR45","doi-asserted-by":"publisher","first-page":"101595","DOI":"10.1016\/j.ajogmf.2024.101595","volume":"7","author":"S Wodoslawsky","year":"2025","unstructured":"Wodoslawsky S, Khanuja K, Saccone G, Hoffman MK, Berghella V (2025) Low-dose aspirin use in low-risk nulliparous pregnancies: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol MFM 7(2):101595","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"2","key":"2353_CR46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1055\/a-2565-9272","volume":"43","author":"AR Kern-Goldberger","year":"2026","unstructured":"Kern-Goldberger AR, Sandhu K, Dolin CD, Bajan A, Raiff E, Lappen JR (2026) The Impact of Universalizing Aspirin Prophylaxis on Treatment Provision for High-Risk Pregnant Patients. Am J Perinatol 43(2):272\u2013274.https:\/\/doi.org\/10.1055\/a-2565-9272. Epub 2025 Mar 25. PMID: 40132985","journal-title":"Am J Perinatol"},{"issue":"7","key":"2353_CR48","doi-asserted-by":"publisher","first-page":"e096779","DOI":"10.1136\/bmjopen-2024-096779","volume":"15","author":"A Khander","year":"2025","unstructured":"Khander A, Matthews K, Christos P, Thomas C, Alam T, Alcus C, Bush L, Edusei E, August P, Malha L (2025) Randomised controlled trial comparing low doses of aspirin in the prevention of pre-eclampsia (ASAPP): a study protocol. BMJ Open 15(7):e096779.https:\/\/doi.org\/10.1136\/bmjopen-2024-096779. PMID: 40633954; PMCID: PMC12243580","journal-title":"BMJ Open"},{"key":"2353_CR49","doi-asserted-by":"publisher","first-page":"1414697","DOI":"10.3389\/fmed.2024.1414697","volume":"11","author":"F Zhang","year":"2024","unstructured":"Zhang F, Wang H (2024) Effect of low-dose aspirin intervention on pre-eclampsia prevention in high-risk pregnant women and its impact on postpartum hemorrhage. Front Med (Lausanne) 11:1414697.https:\/\/doi.org\/10.3389\/fmed.2024.1414697. PMID: 39526246; PMCID: PMC11543432","journal-title":"Front Med (Lausanne)"},{"issue":"13","key":"2353_CR50","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1055\/a-2096-5199","volume":"40","author":"KJ White","year":"2023","unstructured":"White KJ, Son M, Lundsberg LS, Culhane JF, Partridge C, Reddy UM, Merriam AA (2023) Low-Dose Aspirin during Pregnancy and Postpartum Bleeding. Am J Perinatol 40(13):1390\u20131397. https:\/\/doi.org\/10.1055\/a-2096-5199. Epub 2023 Sep 18. PMID: 37211010","journal-title":"Am J Perinatol"},{"key":"2353_CR51","doi-asserted-by":"publisher","unstructured":"Werler MM, Mitchell AA, Shapiro S (1989) The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med. ;321(24):1639-42.https:\/\/doi.org\/10.1056\/NEJM198912143212404. PMID: 2586566","DOI":"10.1056\/NEJM198912143212404"},{"key":"2353_CR52","unstructured":"Kozer E, Nikfar S, Costei A et al (2002) Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis. In: Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK69153\/"},{"issue":"3","key":"2353_CR53","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","volume":"192","author":"Bente;Puh\u00f3 N\u00f8rg\u00e5rd","year":"2005","unstructured":"N\u00f8rg\u00e5rd Bente;Puh\u00f3, Czeizel Erzs\u00e9bet, Skriver AE, S\u00f8rensen MV, Henrik T (2005) Aspirin use during early pregnancy and the risk of congenital abnormalities: A population-based case-control study. Am J Obstet Gynecol 192(3):922\u2013923. https:\/\/doi.org\/10.1016\/j.ajog.2004.10.598","journal-title":"Am J Obstet Gynecol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02353-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:12:07Z","timestamp":1788963127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02353-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2353"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02353-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}